Advanced Enzyme Technologies Limited (ADVENZYMES) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Advanced Enzyme Technologies Limited (ADVENZYMES) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs647.13 Million ≈ $7.00 Million USD) by net assets (Rs15.34 Billion ≈ $165.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Advanced Enzyme Technologies Limited - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Advanced Enzyme Technologies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Advanced Enzyme Technologies Limited total liabilities for a breakdown of total debt and financial obligations.

Advanced Enzyme Technologies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Advanced Enzyme Technologies Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
DBV Technologies S.A. PA:DBV	-0.614x
Poongsan Holdi KO:005810	0.011x
Lexeo Therapeutics, Inc. Common Stock NASDAQ:LXEO	-0.245x
Zhejiang Wanfeng Chemical Co. Ltd. A SHG:603172	N/A
Suzhou Harmontronics Auto Tech Co Ltd SHG:688022	-0.032x
The York Water Company NASDAQ:YORW	0.033x
Concord Securities Co Ltd TWO:6016	0.234x
MediaAlpha Inc. NYSE:MAX	-0.359x

Annual Cash Flow Conversion Efficiency for Advanced Enzyme Technologies Limited (2008–2025)

The table below shows the annual cash flow conversion efficiency of Advanced Enzyme Technologies Limited from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Advanced Enzyme Technologies Limited (ADVENZYMES) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs14.69 Billion ≈ $158.83 Million	Rs1.49 Billion ≈ $16.12 Million	0.102x	-1.54%
2024-03-31	Rs13.71 Billion ≈ $148.28 Million	Rs1.41 Billion ≈ $15.29 Million	0.103x	-5.67%
2023-03-31	Rs12.84 Billion ≈ $138.88 Million	Rs1.40 Billion ≈ $15.18 Million	0.109x	+1.93%
2022-03-31	Rs11.40 Billion ≈ $123.33 Million	Rs1.22 Billion ≈ $13.23 Million	0.107x	-32.14%
2021-03-31	Rs10.31 Billion ≈ $111.47 Million	Rs1.63 Billion ≈ $17.62 Million	0.158x	-2.71%
2020-03-31	Rs8.67 Billion ≈ $93.81 Million	Rs1.41 Billion ≈ $15.24 Million	0.162x	-10.95%
2019-03-31	Rs7.05 Billion ≈ $76.22 Million	Rs1.29 Billion ≈ $13.90 Million	0.182x	-8.51%
2018-03-31	Rs5.82 Billion ≈ $62.91 Million	Rs1.16 Billion ≈ $12.54 Million	0.199x	-12.24%
2017-03-31	Rs4.73 Billion ≈ $51.10 Million	Rs1.07 Billion ≈ $11.61 Million	0.227x	-34.12%
2016-03-31	Rs2.83 Billion ≈ $30.65 Million	Rs977.51 Million ≈ $10.57 Million	0.345x	+38.92%
2015-03-31	Rs2.16 Billion ≈ $23.41 Million	Rs537.31 Million ≈ $5.81 Million	0.248x	-23.58%
2014-03-31	Rs1.71 Billion ≈ $18.50 Million	Rs555.67 Million ≈ $6.01 Million	0.325x	+31.07%
2013-03-31	Rs1.66 Billion ≈ $17.94 Million	Rs411.24 Million ≈ $4.45 Million	0.248x	-73.06%
2012-03-31	Rs984.09 Million ≈ $10.64 Million	Rs905.46 Million ≈ $9.79 Million	0.920x	+4950.18%
2011-03-31	Rs645.35 Million ≈ $6.98 Million	Rs11.76 Million ≈ $127.15K	0.018x	-91.07%
2010-03-31	Rs489.29 Million ≈ $5.29 Million	Rs99.82 Million ≈ $1.08 Million	0.204x	-30.61%
2009-03-31	Rs379.81 Million ≈ $4.11 Million	Rs111.66 Million ≈ $1.21 Million	0.294x	+56.82%
2008-03-31	Rs319.19 Million ≈ $3.45 Million	Rs59.84 Million ≈ $647.15K	0.187x	--

About Advanced Enzyme Technologies Limited

NSE:ADVENZYMES India Specialty Chemicals

Market Cap

$420.87 Million

Rs38.92 Billion INR

Market Cap Rank

#13438 Global

#635 in India

Share Price

Rs347.70

Change (1 day)

+2.95%

52-Week Range

Rs255.30 - Rs360.35

All Time High

Rs549.90